Björn Schaap
Senior Investment Manager at Oost NL
📍 Zwolle, Overijssel, Netherlands
As a Senior Investment Manager for Health at Oost NL, Björn Schaap focuses on early-stage life sciences companies. He holds an MSc from Rotterdam School of Management and an Executive Master in M&A and Valuation. He actively supports portfolio companies developing novel treatments for conditions like Parkinsons disease.
He is passionate about supporting what he calls "echt ondernemerschap" (true entrepreneurship) to help bring new medical treatments from the lab to patients.
Read the full overview →Experience
6 Years
Current Role
Senior Investment Manager
Job Level
Middle
Location
Zwolle, Overijssel, Netherlands
Personality Overview
Personality insights not availableWe need more social data to generate the DISC analysis and selling playbook. The professional details below are still available.
Priorities
Topics Björn cares about
Life Sciences VC
As a Senior Investment Manager at Oost NL, he actively finds and funds promising early-stage companies in the health and biotech sectors.
Therapeutic Innovation
He is directly involved with companies developing novel treatments, including Mair Therapeutics (neurodegenerative disorders) and Tagworks (oncology).
Career
Work history
1-2024
Senior Investment Manager
Oost NL
9-2019 - 1-2024
Investment Manager
Oost NL
3-2025
Shareholder Representative
Mair Therapeutics
1-2024
Board Observer
Delta Life Science
2-2022
Shareholder Representative
Aiosyn
In the press
Media appearances
No media yetWe could not find public media appearances for this person.
Education
2010 - 2011
Master of Science (MSc)
Rotterdam School of Management, Erasmus University
2017 - 2019
Executive Master of M&A and Valuation
University of Groningen
Social presence
More profiles
Discover additional public profiles from our index.
Search more profiles
Looking for someone else? Search here for anyone.